URIMIX ORAL SOLUTION

देश: मलेशिया

भाषा: अंग्रेज़ी

स्रोत: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

सक्रिय संघटक:

Citric Acid Monohydrate; POTASSIUM CITRATE

थमां उपलब्ध:

Noripharma Sdn. Bhd.

INN (इंटरनेशनल नाम):

Citric Acid Monohydrate; POTASSIUM CITRATE

पैकेज में यूनिट:

60 ml; 60 ml; 60 ml; 60 ml; 120 ml; 120 ml; 120 ml; 120 ml; 100 ml; 100 ml; 100 ml; 100 ml

द्वारा बनाया गया:

Noripharma Sdn. Bhd.

सूचना पत्रक

_ _
_ _
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
URIMIX ORAL SOLUTION
Potassium Citrate / Citric acid monohydrate (3g or 30%w/v and 0.5g or
5%w/v)
1
WHAT IS IN THIS LEAFLET
1.
What URIMIX is used for
2.
How URIMIX works
3.
Before you take URIMIX
4.
How to take URIMIX
5.
While you are using URIMIX
6.
Side effects
7.
Storage and Disposal of
URIMIX
8.
Product Description
9 Manufacturer
and
Product
Registration Holder
10.
Date of Revision
11.
Serial Number
WHAT URIMIX IS USED FOR
URIMIX is indicated for relief of
discomfort in mild urinary tract
infections and alkalinisation of urine.
HOW URIMIX WORKS
Potassium Citrate has the action to
make the urine alkaline.
BEFORE YOU USE URIMIX
_- When you must not take it _
Do
not
take
URIMIX
if
you
are
allergic
to
any
medicine
containing
citric acid monohydrate or potassium
citrate.
URIMIX should not be used in patient
with lung, heart, kidney problems or
low
stomach
acid.
Pregnancy
and
lactation
URIMIX
should
be
used
with caution in pregnancy and breast-
feeding.
Ask
your
doctor
or
pharmacist
for
advice
before
taking
any medicine.
_- Before you start to use it _
Your doctor will tell you how much
and how often to take URIMIX.
Tell your doctor or pharmacist if you
have allergies to any other medicines,
food, preservatives or dyes..
_-Taking other medicines _
Tell
your pharmacist the medicines,
including any that you get without a
prescription
from
your
pharmacy,
supermarket
or
health
food
shop.
Some
medicines
and
URIMIX
may
interfere
with
each
other.
These
include:

medicines
used
to
treat
heart
disease

medicines
used
to
treat
kidney
impairment.
These medicines may be affected by
URIMIX
or
may
affect
how
well
it
works.
Your
doctor
and
pharmacist
have more information on medicines to
be careful with or avoid while taking
this medicine.
HOW TO USE URIMIX
Follow all directions given to you by
your pharmacist or doctor carefully.
_-_
_ _
_How much to take _
ADULT
: 15-30 ml well diluted with
water.
CHILDREN_ _
-Up to 1 year: 2.5 ml 3 times daily;
-1 to 5 years: 5

उत्पाद विशेषताएं

URIMIX ORAL SOLUTION
1
COMPOSITION
EACH 10ML CONTAINS:
Potassium citrate:
3g
Citric Acid Monohydrate :
0.5g
PRESERVATIVE:
Sodium Benzoate
10mg
PRODUCT DESCRIPTION
Clear to slight haze liquid having lemon flavor.
PHARMACODYNAMICS
Potassium citrate and citric acid solutions are systematic and urinary
alkalinizers thereby providing
symptomatic relief of dysuria.
PHARMACOKINETICS
Potassium Citrate is absorbed and the citrate is metabolised to
bicarbonate. Citric acid is
metabolised to carbon dioxide and water. Oxidation is virtually
complete with less than 5% of
citrate being excreted unchanged in the urine.
INDICATION
For systemic or urine alkalinisation
For the symptomatic relief of dysuria associated with mild urinary
tract infections, especially
cystitis.
RECOMMENDED DOSAGE
ADULT: 15-30 ml well diluted with water.
CHILDREN
Up to 1 year: 2.5 ml 3 times daily;
1 to 5 years: 5 ml 3 times daily;
6 to 12 years: 10 ml 3 times daily.
To be taken well diluted with water, after meals and at bedtime.
ROUTE OF ADMINISTRATION
Oral
CONTRAINDICATIONS
Hypersensitivity to Potassium Citrate or Citric Acid or any of the
other ingredients/components of
the product. Severe renal impairment with oliguria or azotemia,
untreated Addison's disease,
adynamia episodica hereditaria, acute dehydration, heat cramps,
anuria, severe myocardial
damage, and hyperkalemia from any cause.
URIMIX ORAL SOLUTION
2
WARNING AND PRECAUTIONS
Large doses may cause hyperkalemia and alkalosis, especially in the
presence of renal disease.
Concurrent administration of potassium-containing medication,
potassium-sparing diuretics,
angiotensinconverting enzyme (ACE) inhibitors, or cardiac glycosides
may lead to toxicity.
Should be used with caution by patients with low urinary output unless
under the supervision of a
physician. As with all liquids containing a high concentration of
potassium, patients should be
directed to dilute adequately with water to minimize the possibility
of gastrointestinal injury
associated with the oral ingestion of concentrated potassi